What Genes Experience:Environmental Moderators of Genetic Risk in MIDUS
What Genes Experience:Environmental Moderators of Genetic Risk in MIDUS
批准号:
8719412
负责人:
Craig S Atwood
金额:
$15.0万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-15 至 2015-08-31
关键词:
AdultAgeAgingAmericanAnti-Inflammatory AgentsAnti-inflammatoryAnxietyArchivesAttentionBehavioral GeneticsBiologicalBiological MarkersCandidate Disease GeneCognitionCognitiveCommunitiesComplexCountryDNADataData CollectionData SetDisadvantagedDiseaseEducational workshopElderlyEmotionalEnvironmentEnvironmental ExposureEnvironmental Risk FactorEpidemiologyEpisodic memoryExposure toFundingFutureGenesGeneticGenetic MarkersGenetic ResearchGenetic RiskGenotypeGrantHealthInflammationInflammatoryInterdisciplinary StudyInterleukin-6KnowledgeLinkLiteratureLongitudinal StudiesMailsMeasuresMental DepressionMolecular GeneticsMorbidity - disease rateNeurotic DisordersOther GeneticsOutcomePathway interactionsPositioning AttributeProceduresProcessProductivityProliferatingPsychosocial Assessment and CarePublicationsRecruitment ActivityResearchRespondentRiskRisk FactorsRoleSalivaSample SizeSamplingScientistSocioeconomic StatusSyndromeTestingTissue SampleTwin Multiple BirthWorkbasecognitive functioncomputerizeddesignemerging adultemotional distressexecutive functionexperienceinnovationmembermiddle agemortalityneurobiological mechanismprogramsrepositorysocialsocioeconomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The central objective of the proposed research is to launch a new era of molecular genetics in a large national study of American adults, known as MIDUS (Midlife in the U.S.). Begun in 1995, MIDUS has become a major forum for multidisciplinary research on aging from early adulthood through later life, with a huge following from the scientific community (most frequently downloaded dataset at the national Archive of Computerized Data on Aging). Scientific productive from the study is extensive (about 400 publications), key themes of which clarify that the primary competitive advantage of MIDUS for molecular genetics is its comprehensive and cumulative assessments of environmental exposures. We will focus on two key exposures, socioeconomic status (SES) and social relationships (SR), which constitute well established influences on morbidity and mortality from social epidemiology. We build our specific aims around an explicit gene by environment approach to three outcomes: emotional distress, cognition, and inflammation. In each (Aims 1 through 3), we target primary genetic markers (i.e., those receiving the lion's share of attention in prior research as well as those for which there are functional rationales with regard to underlying neurobiological mechanisms) and examine the role of SES and SR environmental exposures as moderators of their influence on outcomes. Incorporating both risk and protective moderators, we will focus on cumulative SES disadvantage and cumulative SR advantage. An additional set of provisional genetic markers will also be included as supplemental analyses. The proposed work will be carried out with members of the MIDUS Refresher sample (newly recruited respondents) and the existing longitudinal sample (projected sample size for testing key gene by environment hypotheses is 5,400 adults). Embedded within MIDUS is also a national sample of twins for which additional gene by environment analyses will be conducted as well as analyses guided by a co-twin control design. A final aim of the proposed research is to create a genetic repository from the saliva-based DNA extraction and to then hold workshops in the final two years of the grant drawing on scientists from around the country to discuss plans to optimally leverage the use of this repository in a national study with unprecedented depth in assessment of diverse environmental exposures, only two of which are investigated in the proposed research. Overall, the future scientific inquiry that will emanate from the proposed plans to bring molecular genetics to MIDUS is of exceptional scope.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The LUCINDA Trial
-
批准号:10412901
-
项目类别:
-
资助金额:$136.64万
-
财政年份:2018
-
负责人:Craig S Atwood
-
依托单位:
The LUCINDA Trial
-
批准号:9988337
-
项目类别:
-
资助金额:$141.31万
-
财政年份:2018
-
负责人:Craig S Atwood
-
依托单位:
The LUCINDA Trial
-
批准号:9933921
-
项目类别:
-
资助金额:$146.31万
-
财政年份:2018
-
负责人:Craig S Atwood
-
依托单位:
The LUCINDA Trial
-
批准号:9597000
-
项目类别:
-
资助金额:$160.37万
-
财政年份:2018
-
负责人:Craig S Atwood
-
依托单位:
Epistasis in Steroidogenic Genes in the Prediction of Alzheimer's Disease
-
批准号:8440478
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Craig S Atwood
-
依托单位:
Epistasis in Steroidogenic Genes in the Prediction of Alzheimer's Disease
-
批准号:8598792
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Craig S Atwood
-
依托单位:
Antiapoptotic Activity of Alzheimer Abeta
-
批准号:6631585
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2001
-
负责人:Craig S Atwood
-
依托单位:
Antiapoptotic Activity of Alzheimer Abeta
-
批准号:6509977
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2001
-
负责人:Craig S Atwood
-
依托单位:
Antiapoptotic Activity of Alzheimer Abeta
-
批准号:6321451
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2001
-
负责人:Craig S Atwood
-
依托单位:
REDOX METAL IONS AND NEURONAL PROTEIN DEPOSITION
-
批准号:2859119
-
项目类别:
-
资助金额:$8.55万
-
财政年份:1999
-
负责人:Craig S Atwood
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: